Chávez BOA, Carrasco CAL, Martínez-López M, Roldán-Valadez E

Language: Spanish
References: 17
Page: 197-202
PDF size: 255.42 Kb.

ABSTRACT

Cholangiocarcinoma is the second most common cause of liver malignancies, and, even though it has a characteristic clinic presentation, and consequently, its diagnosis is easy, some cases are atypical in its presentation. The utility of image studies is essential to make diagnosis, discriminate different presentations, confirm the localization, extension, dissemination of the tumor, and the invasion to venous or arterial vessels; in the case of magnetic resonance cholangiopancreatography, it clearly defines the limits of intraductal extension. All these information allow radiologists and clinicians to stage and decide the therapeutical options, and in the cases of resectable tumor even to plan the surgery. In this case we present a brief review and classic imaging findings of this pathology specially focused in the MRI.

REFERENCES

1. Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: current and novel imaging techniques. Radiographics 2008; 28: 1263-87.

2. Bloom CM, Langer B, Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999; 19: 1199-218.

3. Kasper ea. Harrison’s principles of Internal Medicine. 2005: 536.

4. Lee JH, Yang HM, Bak UB, Rim HJ. Promoting role of Clonorchis sinensis infection on induction of cholangiocarcinoma during two-step carcinogenesis. Korean J Parasitol 1994; 32: 13-8.

5. Donato F, Gelatti U, Tagger A, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12: 959-64.

6. Levi S, Urbano-Ispizua A, Gill R, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991; 51: 3497-502.

7. Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 2006; 11: 913-22.

8. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69: 1633-7.

9. Burger I, Hong K, Schulick R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 2005; 16: 353-61.

10. Neumaier CE, Bertolotto M, Perrone R, Martinoli C, Loria F, Silvestri E. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 1995; 23: 173-8.

11. Van Thiel DH, Wright HI, Fagiuoli S, Caraceni P, Rodriguez-Rilo H. Preoperative evaluation of a patient for hepatic surgery. J Surg Oncol Suppl 1993; 3: 49-51.

12. Venook AP, Althaus B, Warren RS. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med 2000; 342: 1524; author reply 6-7.

13. Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 1998; 16: 993-1003.

14. Elsayes KM, Narra VR, Yin Y, Mukundan G, Lammle M, Brown JJ. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005; 25: 1299-320.

15. Zidi SH, Prat F, Le Guen O, Rondeau Y, Pelletier G. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000; 46: 103-6.

16. Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a metaanalysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139: 547-57.

17. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999; 173: 393-8.